Pneumonia recovery reprograms the alveolar macrophage pool.
Guillon A, Arafa EI, Barker KA, Belkina AC, Martin I, Shenoy AT, Wooten AK, Lyon De Ana C, Dai A, Labadorf A, Hernandez Escalante J, Dooms H, Blasco H, Traber KE, Jones MR, Quinton LJ, Mizgerd JP.
JCI Insight. 2020 Feb 27;5(4):e133042. doi: 10.1172/jci.insight.133042.
Recruitment and training of alveolar macrophages after pneumococcal pneumonia.
Arafa EI, Shenoy AT, Barker KA, Etesami NS, Martin IM, Lyon De Ana C, Na E, Odom CV, Goltry WN, Korkmaz FT, Wooten AK, Belkina AC, Guillon A, Forsberg EC, Jones MR, Quinton LJ, Mizgerd JP.
JCI Insight. 2022 Mar 8;7(5):e150239. doi: 10.1172/jci.insight.150239.
The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy.
Anderson R, Feldman C.
Int J Mol Sci. 2023 Jul 3;24(13):11038. doi: 10.3390/ijms241311038.
Type I Interferon Targets Alveolar Macrophages to Promote Bacterial Pneumonia after Viral Infection.
Palani S, Uddin MB, McKelvey M, Shao S, Wu W, Bao X, Sun J, Sun K.
Am J Respir Cell Mol Biol. 2025 Aug;73(2):264-274. doi: 10.1165/rcmb.2024-0552OC.
Respiratory exposure to 6PPD-quinone aggravates Klebsiella pneumoniae pneumonia by impairing the innate immune function of alveolar macrophages.
Qiu XW, Zhang W, Chen X, Luo G, Qi X, Guo Q, Zhou X, Sun X, Xiang H, Feng H, Wen X, Bai S.
J Hazard Mater. 2025 Sep 15;496:139277. doi: 10.1016/j.jhazmat.2025.139277. Epub 2025 Jul 16.
TNF superfamily member 14 drives post-influenza depletion of alveolar macrophages, enabling secondary pneumococcal pneumonia.
Malainou C, Peteranderl C, Ferrero MR, Vazquez-Armendariz AI, Alexopoulos I, Franz K, Knippenberg K, Better J, Estiri M, Wu CY, Schultheis H, Bushe J, Del Rio ML, Rodriguez-Barbosa JI, Pfeffer K, Günther S, Looso M, Gruber AD, Vadász I, Matt U, Herold S.
J Clin Invest. 2025 Nov 18;136(2):e185390. doi: 10.1172/JCI185390. eCollection 2026 Jan 16.
Segmented filamentous bacteria reprogramming of alveolar macrophages limits postinfluenza bacterial pneumonia.
Ngo VL, Lieber CM, Abo H, Kuczma M, Zou J, Plemper RK, Gewirtz AT.
Sci Immunol. 2026 Jan 2;11(115):eadt8858. doi: 10.1126/sciimmunol.adt8858. Epub 2026 Jan 2.
Plasmin modulates neutrophilic inflammation and alveolar macrophage function, protecting mice from pneumococcal pneumonia.
Cardoso C, Carvalho AFS, Lara ES, Carneiro FS, Zaidan I, Grossi LC, Montuori-Andrade ACM, Souza JAM, Felix FB, Monteiro AHA, Lima EB, Augusto IL, Caixeta RS, Barbosa BCM, Queiroz-Junior CM, Russo RC, Pinho V, Vago JP, Sugimoto MA, Costa VV, Miles LA, Parmer RJ, Braga FC, Teixeira MM, Tavares LP, Sousa LP.
Blood. 2026 Apr 30;147(18):2098-2113. doi: 10.1182/blood.2025028733.
Mechanism of chlorogenic acid in alveolar macrophage polarization in Klebsiella pneumoniae-induced pneumonia.
Li QR, Tan SR, Yang L, He W, Chen L, Shen FX, Wang Z, Wang HF.
J Leukoc Biol. 2022 Jul;112(1):9-21. doi: 10.1002/JLB.3HI0721-368R. Epub 2021 Sep 29.
Alveolar Macrophage Apoptosis-associated Bacterial Killing Helps Prevent Murine Pneumonia.
Preston JA, Bewley MA, Marriott HM, McGarry Houghton A, Mohasin M, Jubrail J, Morris L, Stephenson YL, Cross S, Greaves DR, Craig RW, van Rooijen N, Bingle CD, Read RC, Mitchell TJ, Whyte MKB, Shapiro SD, Dockrell DH.
Am J Respir Crit Care Med. 2019 Jul 1;200(1):84-97. doi: 10.1164/rccm.201804-0646OC.
